Browsing by Author Voulgari, P. V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 35 to 54 of 109 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximabPaschou, S.; Voulgari, P. V.; Vrabie, I. G.; Saougou, I. G.; Drosos, A. A.24-Nov-2015-
Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literatureVoulgari, P. V.; Katsimbri, P.; Alamanos, Y.; Drosos, A. A.24-Nov-2015-
Gingival hyperplasia associated with cyclosporin AVoulgari, P. V.; Drosos, A. A.24-Nov-2015-
Glucocorticoid receptor variants may predispose to rheumatoid arthritis susceptibilityChatzikyriakidou, A.; Georgiou, I.; Voulgari, P. V.; Georgiadis, A. N.; Argyriou, E.; Drosos, A. A.24-Nov-2015-
Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisVoulgari, P. V.24-Nov-2015-
Granuloma annulare induced by anti-tumour necrosis factor therapyVoulgari, P. V.; Markatseli, T. E.; Exarchou, S. A.; Zioga, A.; Drosos, A. A.24-Nov-2015-
Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatmentNikas, S. N.; Voulgari, P. V.; Takalou, I. P.; Katsimbri, P.; Drosos, A. A.24-Nov-2015-
Heterotopic ossification in systemic sclerosisBotzoris, V.; Argyropoulou, M. I.; Voulgari, P. V.; Zikou, A. K.; Drosos, A. A.24-Nov-2015-
Identification of the semaphorin receptor Plexin-A2 as a candidate gene for susceptibility to ankylosing spondylitisChatzikyriakidou, A.; Voulgari, P. V.; Georgiou, I.; Drosos, A. A.24-Nov-2015-
Images in rheumatology. Transfusion-related acute lung injury during intravenous immunoglobulin treatmentVoulgari, P. V.; Paschou, S.; Svarna, E.; Tsifetaki, N.; Drosos, A. A.24-Nov-2015-
Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitorsExarchou, S. A.; Voulgari, P. V.; Markatseli, T. E.; Zioga, A.; Drosos, A. A.24-Nov-2015-
The impact of life events on patients with rheumatoid arthritisDamigos, D.; Siafaka, V.; Voulgari, P. V.; Liakos, A.; Drosos, A. A.24-Nov-2015-
The impact of psychological functioning upon systemic sclerosis patients' quality of lifeHyphantis, T. N.; Tsifetaki, N.; Siafaka, V.; Voulgari, P. V.; Pappa, C.; Bai, M.; Palieraki, K.; Venetsanopoulou, A.; Mavreas, V.; Drosos, A. A.24-Nov-2015-
Incidence and prevalence of psoriatic arthritis: a systematic reviewAlamanos, Y.; Voulgari, P. V.; Drosos, A. A.24-Nov-2015-
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic reviewAlamanos, Y.; Voulgari, P. V.; Drosos, A. A.24-Nov-2015-
Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximabMarkatseli, T. E.; Kaltsonoudis, E. S.; Voulgari, P. V.; Zioga, A.; Drosos, A. A.24-Nov-2015-
Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experienceVoulgari, P. V.; Venetsanopoulou, A. I.; Epagelis, E. K.; Alamanos, Y.; Takalou, I.; Drosos, A. A.24-Nov-2015-
Infliximab therapy in established rheumatoid arthritis: an observational studyVoulgari, P. V.; Alamanos, Y.; Nikas, S. N.; Bougias, D. V.; Temekonidis, T. I.; Drosos, A. A.24-Nov-2015-
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month studyTemekonidis, T. I.; Alamanos, Y.; Nikas, S. N.; Bougias, D. V.; Georgiadis, A. N.; Voulgari, P. V.; Drosos, A. A.24-Nov-2015-
Infliximab treatment in ankylosing spondylitis: an observational studyNikas, S. N.; Alamanos, Y.; Voulgari, P. V.; Pliakou, X. I.; Papadopoulos, C. G.; Drosos, A. A.24-Nov-2015-